Immune Modulator Drugs Improved Survival for People Hospitalized with COVID-19
June 2, 2022 -- A large randomized, placebo-controlled clinical trial led by the National Institutes of Health shows that treating adults hospitalized with COVID-19 with infliximab or abatacept– drugs widely used to treat certain autoimmune... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - June 2, 2022 Category: Pharmaceuticals Source Type: clinical trials
A Multicentered Prospective Cohort Study of Chinese IBD Patients
Conditions: Ulcerative Colitis; Crohn Disease Interventions: Drug: Infliximab; Drug: Vedolizumab; Drug: Ustekinumab; Drug: conventional treatment (glucocoticoid, immunosupressive drugs and/or mesalazine) Sponsor: Peking Union Medical College Hospital Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 23, 2022 Category: Research Source Type: clinical trials
